Events Archive

LEN Learning Clinic: Innovations in Service Delivery & Facility-Level Implementation

This interactive learning clinic brings together governments, implementing partners, and technical assistance teams to share and discuss early insights from LEN introduction — with a focus on practical service delivery innovations from the field. This will be interactive— come ready to engage. Featured Speakers: Dr Chimika Phiri, Ministry of Health, Zambia- Early insights from Zambia’s…

The Injectors of Tomorrow are Here Today

An important part of expanding PrEP access includes increasing the number of individuals who can deliver PrEP, particularly injectable PrEP, and the locations where PrEP can be administered and obtained. Join The Choice Agenda to hear from community health workers and pharmacists who are taking actions outside the box such as learning to inject, and…

Dapivirine Ring: Giving Women Hope and Choice in HIV Prevention

Recording / Transcript / Slides / Resources The monthly Dapivirine Vaginal Ring (DVR) is a critical option in the HIV prevention toolkit, being entirely woman controlled, discrete, and very safe and simple to implement. This webinar will highlight ongoing Market Access activities to ensure women have access to the monthly DVR; key learnings from community…

Innovative HIV Prevention and Treatment Keynote and Panel Discussion

Can a Twice-Yearly PrEP Injection Curb the HIV Pandemic? Join the O’Neill Institute for an in-depth discussion on Lenacapavir, a groundbreaking long-acting injectable PrEP formulation administered just twice a year. This session will examine its potential to transform HIV prevention on a global scale, looking at the latest clinical evidence, regulatory pathways, and the access…

Self-care Approach to HIV Prevention

How can self-care transform HIV prevention? Join SSLN on Thursday, October 23, 2025, to explore the future of self-care in HIV prevention programming. This crucial session will equip country champions and stakeholders with the technical knowledge and practical tools needed to lead the way. We will cover the risks and opportunities, outline actionable first steps…

The New Frontier in HIV Pre-exposure Prophylaxis: Lenacapavir Update

In the ongoing search for new methods to address the HIV epidemic, the development of lenacapavir for HIV prevention is a major step forward. Findings from research studies has shown that twice-yearly injection of long-acting lenacapavir provides protection against HIV infection. This discovery offers great promise in advancing our progress towards ending AIDS as a…

Modernising Demand Generation for HIV Prevention

With HIV prevention budgets under increasing pressure, effective and efficient communication is more vital than ever. As prevention options expand from condoms and HIV self-testing to multiple forms of PrEP tailored, impactful demand creation is essential to drive uptake and support informed choice. This session will explore how to generate demand using data-informed strategies, virtual…

From Oral PrEP to LEN: Leveling Up Prevention with the WHO–Jhpiego PrEP Provider Training Toolkit

Recording / Slides This 90-minute webinar, presented by Jhpiego and WHO, is intended for communities, providers, policy makers and advocates interested in pre-exposure prophylaxis (PrEP) for HIV prevention. The presenters will provide an overview of the recently launched WHO and Jhpiego Provider Training Toolkit on Use of Oral and Long-Acting HIV PrEP with case-based scenarios…

HIV Prevention Re-mix: Current tools, new tools, same goal

Join the UNITED! Movement and AVAC to learn more about the future of HIV prevention and what this means for young people. The webinar will cover: Prevention options currently available Long-acting PrEP products, including those currently available, available soon, and in the pipeline An update on the introduction of six month lenacapavir for PrEP Advocacy…

Will Lenacapavir be a lever or a let-down? Lessons, Resources, and Considerations for Implementation in the United States

Lenacapavir for PrEP has tremendous potential to increase access and engagement in the United States, reaching individuals who have been unable to embrace PrEP in its previous formulations. How can we ensure that our implementation lifts up, rather than lets down, individuals and communities who need this innovation most? What can we learn from past…